NCT04321746View on ClinicalTrials.gov

The Effect of Ketamine on Postoperative Cognitive Dysfunction.

PHASE4CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

December 10, 2020

Primary Completion Date

March 8, 2022

Study Completion Date

March 9, 2022

Conditions
Postoperative Cognitive Dysfunction
Interventions
DRUG

Ketamine

ketamine will be administered at a dose of 0.3 mg/kg in normal saline at 0.9% (250 mL)

OTHER

Placebo

the control group will receive only normal saline at 0.9%, with the same physical characteristics of the ketamine solution

Trial Locations (1)

11111

Assiut University hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04321746 - The Effect of Ketamine on Postoperative Cognitive Dysfunction. | Biotech Hunter | Biotech Hunter